704 related articles for article (PubMed ID: 7563509)
41. Practice Alert: ACIP vaccine update.
Campos-Outcalt D
J Fam Pract; 2018 Mar; 67(3):155-158. PubMed ID: 29509821
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010.
Kunoee A; Nielsen J; Cowan S
Euro Surveill; 2016; 21(7):pii=30136. PubMed ID: 26923681
[TBL] [Abstract][Full Text] [Related]
43. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.
Boccalini S; Taddei C; Ceccherini V; Bechini A; Levi M; Bartolozzi D; Bonanni P
Hum Vaccin Immunother; 2013 May; 9(5):1119-28. PubMed ID: 23376840
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment.
Hontelez JA; Hahné S; Koedijk FH; de Melker HE
J Epidemiol Community Health; 2010 Oct; 64(10):890-4. PubMed ID: 19822551
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
46. The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China.
Li F; Wang Q; Zhang L; Su H; Zhang J; Wang T; Huang D; Wu J; Yan Y; Fan D
Vaccine; 2012 Nov; 30(49):7118-22. PubMed ID: 23022150
[TBL] [Abstract][Full Text] [Related]
47. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net.
Fischer G; Wang S; Ahring S; Fowler K; Hainline S; Chinglong M; Jacques-Carroll L; Bell B; Williams I
Pediatr Infect Dis J; 2009 Jul; 28(7):593-7. PubMed ID: 19455073
[TBL] [Abstract][Full Text] [Related]
48. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
[TBL] [Abstract][Full Text] [Related]
49. Impact of the national hepatitis B immunization program in China: a modeling study.
Liu Z; Li M; Hutton DW; Wagner AL; Yao Y; Zhu W; Cao L; Tang S; Pan J; Wang Y; Zhao Q; Ren H; Wang Y; Wang W
Infect Dis Poverty; 2022 Oct; 11(1):106. PubMed ID: 36221140
[TBL] [Abstract][Full Text] [Related]
50. The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries.
Chauvin P; Ekra D; Plotkin SA
Vaccine; 2002 Jul; 20(23-24):2848-50. PubMed ID: 12126893
[No Abstract] [Full Text] [Related]
51. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
52. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
53. Survey of Impediments to Prevention of Mother-to-infant Transmission of Hepatitis B Virus by International Societies.
Chang MH; Fischler B; Blauvelt B; Ciocca M; Dhawan A; Ekong U; Ni YH; Porta G; Sibal A; DAgostino D; Wirth S; Morhan N; Schwarz KB
J Pediatr Gastroenterol Nutr; 2019 Dec; 69(6):648-654. PubMed ID: 31503215
[TBL] [Abstract][Full Text] [Related]
54. Implementation of a neonatal hepatitis B immunization program in rural Karenni State, Myanmar: A mixed-methods study.
Guan TH; Htut HN; Davison CM; Sebastian S; Bartels SA; Aung SM; Purkey E
PLoS One; 2021; 16(12):e0261470. PubMed ID: 34928996
[TBL] [Abstract][Full Text] [Related]
55. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the compliance with recommended procedures in newborns exposed to HBsAg-positive mothers: a multicenter collaborative study.
Heininger U; Vaudaux B; Nidecker M; Pfister RE; Posfay-Barbe KM; Bachofner M; Hoigné I; Gnehm HE
Pediatr Infect Dis J; 2010 Mar; 29(3):248-50. PubMed ID: 19935120
[TBL] [Abstract][Full Text] [Related]
57. [Adjustment of the hepatitis-B vaccination scheme for newborns born to hepatitis-B virus carriers as of 1 January 2006].
Geelen SP
Ned Tijdschr Geneeskd; 2006 Feb; 150(8):415-8. PubMed ID: 16538839
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology and prevention of hepatitis B.
Alter MJ
Semin Liver Dis; 2003 Feb; 23(1):39-46. PubMed ID: 12616449
[TBL] [Abstract][Full Text] [Related]
59. Is hepatitis B birth dose vaccine needed in Africa?
Tamandjou CR; Maponga TG; Chotun N; Preiser W; Andersson MI
Pan Afr Med J; 2017; 27(Suppl 3):18. PubMed ID: 29296153
[TBL] [Abstract][Full Text] [Related]
60. Tenofovir prophylaxis for preventing mother-to-child hepatitis B virus transmission in China: A cost-effectiveness analysis.
Yin J; Liang P; Chen G; Wang F; Cui F; Liang X; Zhuang G
Int J Infect Dis; 2020 Jun; 95():118-124. PubMed ID: 32205288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
